POS1250 ASSOCIATION BETWEEN METABOLIC COMORBIDITIES AND RETENTION RATES OF FIRST-LINE b/tsDMARD TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS: EUROPEAN REAL-WORLD RESULTS | Publicación